03309 C-MER MEDICAL
Closed Add to PorfolioKey Financial Ratio (Fiscal Year: 12/2024) | |||
Current | 1.56X | Oper Margin | N/A |
---|---|---|---|
LT Debt/Equity | 16.3% | Net Margin | N/A |
Total Debt/Equity | 23.8% | Return on Equity | N/A |
Price/Book | 1.38X | Return on Assets | N/A |
(HKD 1.930) | 2024-12 | 2023-12 | 2022-12 | 2021-12 | 2020-12 |
Net Profit (MHKD) | -135.16 | 62.00 | -21.88 | 21.86 | -6.25 |
---|---|---|---|---|---|
Net Profit Growth (%) | -318.0 | +383.4 | -200.1 | +450.0 | -115.1 |
Earnings Per Share (HKD) | -0.11 | 0.049 | -0.018 | 0.019 | -0.006 |
Earnings Per Share Growth (%) | -321.9 | +379.1 | -193.2 | +433.3 | -114.4 |
Dividend Per Share (HKD) | 0.020 | No dividend | No dividend | No dividend | 0.020 |
P/E* (X) | N/A | 39.07 | N/A | 101.58 | N/A |
Yield (%) | 1.04 | N/A | N/A | N/A | 1.04 |
Dividend Share (%) | N/A | N/A | N/A | N/A | N/A |
Book NAV (HKD) | 1.396 | 1.470 | 1.473 | 1.157 | 1.128 |
Auditors' Opinion | Unqualified | Unqualified | Unqualified | Unqualified | Unqualified |
Remarks:
1. Unqualified = Not Qualified because the financial statements have been fairly presented in accordance with appropriate accounting standards and companies ordinance.
2. Unqualified # = Not Qualified in respect of fundamental uncertainty because of appropriate disclosures.
3. Qualified = Qualified Opinion in respect of limitation in audit scope and/or disclaimer on view given by financial statements and/or disagreement of accounting treatment and/or adverse opinion.
1. Unqualified = Not Qualified because the financial statements have been fairly presented in accordance with appropriate accounting standards and companies ordinance.
2. Unqualified # = Not Qualified in respect of fundamental uncertainty because of appropriate disclosures.
3. Qualified = Qualified Opinion in respect of limitation in audit scope and/or disclaimer on view given by financial statements and/or disagreement of accounting treatment and/or adverse opinion.
Last Update Time: 2025-09-08 21:40:20
Latest Result
(HKDMn) | 2025-06 | 2024-06 | Chg* (%) | 2023-06 |
Cover Period (mths) | 6 | 6 | NA | 6 |
---|---|---|---|---|
Turnover | 944.325 | 922.501 | +2.4 | 950.263 |
Operating Result | 74.377 | 68.931 | +7.9 | 54.326 |
Associates | -1.271 | -0.241 | +427.4 | 3.426 |
Profit Before Taxation | 75.394 | 68.393 | +10.2 | 57.173 |
Taxation | 19.24 | 19.757 | -2.6 | 19.176 |
Profit /( Loss) After Taxation | 56.154 | 48.636 | +15.5 | 37.997 |
Minority Interests | 6.21 | 17.873 | -65.3 | 8.239 |
Net Profit | 49.944 | 30.763 | +62.4 | 29.758 |
Earnings Per Share () | 0.0411 | 0.0248 | +65.7 | 0.0236 |
Announcement Date | 2025-08-26 | 2024-08-29 | NA | 2023-08-30 |
* Annualised
Last Update Time: 2025-09-08 21:40:25